About
Dr. Jixi Li joined BOCG as Senior Advisor in July 2022, bringing over 20 years of life sciences research experience to inform the firm's view of biotech development and innovation. He is a full professor at the School of Life Sciences at Fudan University and an adjunct professor at Huashan Hospital in Shanghai, holding a bachelor's degree from Zhejiang University (2000) and a Ph.D. from Fudan University (2006), with postdoctoral work at Caltech, Cornell, and Harvard Medical School. His lab studies inflammatory cell death and immune responses, including work on the RIP1/RIP3 necrosome and regulators of pyroptosis and necroptosis.
Invests in
Biotech
Colleagues at Blue Ocean Capital Group
Dr Waleed AI-Shaqha
Science & Strategic Advisor at Blue Ocean Capital Group
Dr. Daniel Tang
Venture Partner at Blue Ocean Capital Group
Dr. Duanqing Pei
Chief Scientist Advisor in Cell & Regenerative Medicine at Blue Ocean Capital Group
Dr. Haibo Qian
Senior Industry Advisor at Blue Ocean Capital Group
Dr. Hua Jiang
Senior Industry Advisor at Blue Ocean Capital Group
Dr. Jean Paul Thiery
Senior Advisor at Blue Ocean Capital Group
Dr. Min Zhuo
Chief Scientific Advisor for Neuroscience at Blue Ocean Capital Group
Dr. Xinye Xiao
Industry Advisor at Blue Ocean Capital Group